Monday, May 29, 2023

HealthSherpa enrolls greater than 3 million folks thru January fifteenth, maximum pay not up to $21/month

-


Word to Media: We will supply state-level mixture knowledge for classes proven right here for healthcare.gov states the place HealthSherpa provides ACA-subsidized insurance policies. Please succeed in out if you happen to’re keen on further knowledge.

The Open Enrollment duration for Plan 12 months 2022 is over, and HealthSherpa has helped greater than 3 million folks in finding protection during the ACA Marketplaces – our most powerful Open Enrollment thus far. 

Significantly, greater than 500,000 folks took good thing about the OEP extension and enrolled for protection that may get started on February 1st, 2022. Maximum enrollees have been in a position to search out high quality, complete protection for $21/month or much less, a testomony to how the American Rescue Plan subsidy expansions have stepped forward affordability at the ACA Marketplaces. (For OE2021, HealthSherpa’s median internet top class was once $54.)

Learn on for extra detailed insights into the 2022 Open Enrollment Duration up to now.

Key Enrollment Metrics, 11/1/2021 – 1/15/2022

HealthSherpa Quantity

HealthSherpa insurance policies: 2,265,719

HealthSherpa lives: 3,345,150

Most sensible States: FL, TX, GA, NC, SC

Prices & subsidies

Proportion claiming a subsidy: 96%

Median Gross Top class: $733.10

Median Internet Top class: $20.93

Median Subsidy: $639.00

% enrolled in $0 plans: 30%

Price-sharing

Gold 4.56% Silver 66.50% Bronze 1.62% Expanded bronze 26.94%

Receiving CSR: 63% general

Demographics

Reasonable Candidates According to Coverage: 1.48

Intercourse of number one applicant: 54% feminine, 46% male

Median age: 48

Number one applicant age distribution: 2% beneath 21 / 15% 21-29 / 18% 30-39 / 21% 40-49 / 27% 50-59 / 19% 60+ 

 

For media inquiries, please touch press@healthsherpa.com

Disclaimer: knowledge indexed this is for federal market states simplest and correct to five%.



LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Stories